Header Logo

Connection

Bruce Fireman to Infant

Back to Details
This is a "connection" page, showing publications Bruce Fireman has written about Infant.
Bruce Fireman
Connection Strength
1.009
Infant
  1. Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics. 2012 May; 129(5):809-14.
    View in: PubMed
    Score: 0.077
  2. Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults. Vaccine. 2006 Apr 12; 24 Suppl 2:S2-79-80.
    View in: PubMed
    Score: 0.051
  3. Incidence and Risk of Coronavirus Disease 2019 Hospitalization Among Unvaccinated Children. Influenza Other Respir Viruses. 2024 Oct; 18(10):e70022.
    View in: PubMed
    Score: 0.046
  4. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J. 2004 Jun; 23(6):485-9.
    View in: PubMed
    Score: 0.045
  5. Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life. Nat Commun. 2023 Feb 28; 14(1):894.
    View in: PubMed
    Score: 0.041
  6. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003 Jan; 22(1):10-6.
    View in: PubMed
    Score: 0.041
  7. Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders. Vaccine. 2022 Apr 20; 40(18):2568-2573.
    View in: PubMed
    Score: 0.039
  8. Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event. Drug Saf. 2020 10; 43(10):1057-1065.
    View in: PubMed
    Score: 0.035
  9. Acellular Pertussis Vaccine Effectiveness Over Time. Pediatrics. 2019 07; 144(1).
    View in: PubMed
    Score: 0.032
  10. Live Attenuated Influenza Vaccination Before 3 Years of Age and Subsequent Development of Asthma: A 14-year Follow-up Study. Pediatr Infect Dis J. 2018 05; 37(5):383-386.
    View in: PubMed
    Score: 0.029
  11. No association between influenza vaccination during pregnancy and adverse birth outcomes. Vaccine. 2017 05 31; 35(24):3186-3190.
    View in: PubMed
    Score: 0.028
  12. Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis. Pediatrics. 2017 May; 139(5).
    View in: PubMed
    Score: 0.027
  13. Risk factors and familial clustering for fever 7-10days after the first dose of measles vaccines. Vaccine. 2017 03 14; 35(12):1615-1621.
    View in: PubMed
    Score: 0.027
  14. Safety of measles-containing vaccines in 1-year-old children. Pediatrics. 2015 Feb; 135(2):e321-9.
    View in: PubMed
    Score: 0.023
  15. Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr. 2013 Dec; 167(12):1111-7.
    View in: PubMed
    Score: 0.022
  16. Implementation of an outpatient electronic health record and emergency department visits, hospitalizations, and office visits among patients with diabetes. JAMA. 2013 Sep 11; 310(10):1060-5.
    View in: PubMed
    Score: 0.021
  17. Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study. Pediatrics. 2013 May; 131(5):e1389-96.
    View in: PubMed
    Score: 0.021
  18. Outpatient electronic health records and the clinical care and outcomes of patients with diabetes mellitus. Ann Intern Med. 2012 Oct 02; 157(7):482-9.
    View in: PubMed
    Score: 0.020
  19. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. Am J Epidemiol. 2012 Jun 01; 175(11):1100-9.
    View in: PubMed
    Score: 0.020
  20. Immunization and Bell's palsy in children: a case-centered analysis. Am J Epidemiol. 2012 May 01; 175(9):878-85.
    View in: PubMed
    Score: 0.019
  21. Lack of association between childhood immunizations and encephalitis in California, 1998-2008. Vaccine. 2012 Jan 05; 30(2):247-53.
    View in: PubMed
    Score: 0.019
  22. H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. Am J Prev Med. 2011 Aug; 41(2):121-8.
    View in: PubMed
    Score: 0.018
  23. Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project. Pediatrics. 2011 May; 127 Suppl 1:S54-64.
    View in: PubMed
    Score: 0.018
  24. Evaluation of immunization rates and safety among children with inborn errors of metabolism. Pediatrics. 2011 May; 127(5):e1139-46.
    View in: PubMed
    Score: 0.018
  25. Evaluation of ventilating tubes and myringotomy in the treatment of recurrent or persistent otitis media. Pediatr Infect Dis J. 1991 Jan; 10(1):2-11.
    View in: PubMed
    Score: 0.018
  26. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics. 2010 Jul; 126(1):e1-8.
    View in: PubMed
    Score: 0.017
  27. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am J Epidemiol. 2010 Jan 15; 171(2):177-88.
    View in: PubMed
    Score: 0.016
  28. Lack of association of Kawasaki disease after immunization in a cohort of infants followed for multiple autoimmune diagnoses in a large, phase-4 observational database safety study of 7-valent pneumococcal conjugate vaccine: lack of association between Kawasaki disease and seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2009 May; 28(5):438-40.
    View in: PubMed
    Score: 0.016
  29. Patterns of infliximab use among Crohn's disease patients in a community setting. Inflamm Bowel Dis. 2008 Sep; 14(9):1265-72.
    View in: PubMed
    Score: 0.015
  30. Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol Psychiatry. 2008 Oct 01; 64(7):583-8.
    View in: PubMed
    Score: 0.015
  31. Brain-derived neurotrophic factor and autism: maternal and infant peripheral blood levels in the Early Markers for Autism (EMA) Study. Autism Res. 2008 Apr; 1(2):130-7.
    View in: PubMed
    Score: 0.015
  32. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007 Sep; 26(9):771-7.
    View in: PubMed
    Score: 0.014
  33. A role for genetics in the immune response to the varicella vaccine. Pediatr Infect Dis J. 2007 Apr; 26(4):300-5.
    View in: PubMed
    Score: 0.014
  34. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J. 2006 Sep; 25(9):779-81.
    View in: PubMed
    Score: 0.013
  35. Early experiences with e-health services (1999-2002): promise, reality, and implications. Med Care. 2006 May; 44(5):491-6.
    View in: PubMed
    Score: 0.013
  36. Use of e-Health services between 1999 and 2002: a growing digital divide. J Am Med Inform Assoc. 2005 Mar-Apr; 12(2):164-71.
    View in: PubMed
    Score: 0.012
  37. Pneumococcal conjugate vaccine in children. N Engl J Med. 2004 Jan 01; 350(1):84-5; author reply 84-5.
    View in: PubMed
    Score: 0.011
  38. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002 Sep; 21(9):810-5.
    View in: PubMed
    Score: 0.010
  39. Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohort. Pediatr Infect Dis J. 2002 Jun; 21(6):568-9.
    View in: PubMed
    Score: 0.010
  40. Observed costs and health care use of children in a randomized controlled trial of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2002 May; 21(5):361-5.
    View in: PubMed
    Score: 0.010
  41. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000 Mar; 19(3):187-95.
    View in: PubMed
    Score: 0.008
  42. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J. 1999 Sep; 18(9):757-63.
    View in: PubMed
    Score: 0.008
  43. Safety and immunogenicity of Chiron/Biocine recombinant acellular pertussis-diphtheria-tetanus vaccine in infants and toddlers. Pediatr Infect Dis J. 1997 Jan; 16(1):53-8.
    View in: PubMed
    Score: 0.007
  44. Effect of a copayment on use of the emergency department in a health maintenance organization. N Engl J Med. 1996 Mar 07; 334(10):635-41.
    View in: PubMed
    Score: 0.006
  45. Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy. The Kaiser Permanente Pediatric Vaccine Study Group. Pediatr Infect Dis J. 1993 Dec; 12(12):981-5.
    View in: PubMed
    Score: 0.005
  46. Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use. J Infect Dis. 1992 Jun; 165 Suppl 1:S139-43.
    View in: PubMed
    Score: 0.005
  47. Apparent decreased risk of invasive bacterial disease after heterologous childhood immunization. Am J Dis Child. 1991 Jul; 145(7):746-9.
    View in: PubMed
    Score: 0.005
  48. Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J. 1991 Feb; 10(2):92-6.
    View in: PubMed
    Score: 0.004
  49. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J. 1991 Feb; 10(2):97-104.
    View in: PubMed
    Score: 0.004

© 2024 Kaiser Permanente